Science Group Bilan de santé

Santé financière contrôle des critères 6/6

Science Group possède un total de capitaux propres de £84.5M et une dette totale de £12.4M, ce qui porte son ratio d'endettement à 14.6%. Son actif total et son passif total sont £136.1M et de £51.5M. L'EBIT de Science Group est £9.4M ce qui fait que son ratio de couverture des intérêts 64.9. Elle dispose de liquidités et de placements à court terme de £38.8M.

Informations clés

14.6%

Ratio d'endettement

UK£12.36m

Dette

Ratio de couverture des intérêts	64.9x
Argent liquide	UK£38.75m
Fonds propres	UK£84.52m
Total du passif	UK£51.54m
Total des actifs	UK£136.06m

Mises à jour récentes de la santé financière

Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet

May 07

Is Science Group (LON:SAG) Using Too Much Debt?

Dec 14

Recent updates

An Intrinsic Calculation For Science Group plc (LON:SAG) Suggests It's 30% Undervalued

Mar 18

Is It Time To Consider Buying Science Group plc (LON:SAG)?

Jun 04

Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet

May 07

Statutory Profit Doesn't Reflect How Good Science Group's (LON:SAG) Earnings Are

Mar 17

Has Science Group plc's (LON:SAG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Mar 12

Shareholders Of Science Group (LON:SAG) Must Be Happy With Their 172% Total Return

Feb 05

Is Science Group (LON:SAG) Using Too Much Debt?

Dec 14

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de SAG ( £65.0M ) dépassent ses passifs à court terme ( £32.4M ).

Passif à long terme: Les actifs à court terme de SAG ( £65.0M ) dépassent ses passifs à long terme ( £19.2M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: SAG dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de SAG a été réduit de 38.3% à 14.6% au cours des 5 dernières années.

Couverture de la dette: La dette de SAG est bien couverte par le flux de trésorerie opérationnel ( 80.7% ).

Couverture des intérêts: Les paiements d'intérêts de SAG sur sa dette sont bien couverts par l'EBIT ( 64.9 x couverture).

Science Group Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet

Is Science Group (LON:SAG) Using Too Much Debt?

Recent updates

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,570,200 shares, representing 10% of its issued share capital, under the authorization approved on June 18, 2024.

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,570,200 shares, representing 10% of its issued share capital, under the authorization approved on June 18, 2024.

First half 2024 earnings released: EPS: UK£0.13 (vs UK£0.12 in 1H 2023)

Upcoming dividend of UK£0.08 per share

Group MD & Director recently sold UK£333k worth of stock

Science Group plc, Annual General Meeting, Jun 18, 2024

Price target increased by 9.1% to UK£6.35

Science Group plc Proposes Final Dividend for 2023, Payable on 19 July 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Science Group plc to Report Fiscal Year 2023 Results on Mar 21, 2024

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

Group MD & Director exercised options and sold UK£1.2m worth of stock

First half 2023 earnings released: EPS: UK£0.12 (vs UK£0.10 in 1H 2022)

Science Group plc (AIM:SAG) commences an Equity Buyback for 4,537,134 shares, representing 10.01% of its issued share capital, , under the authorization approved on May 18, 2023.

Less than half of directors are independent

Science Group plc Approves Final Dividend

Upcoming dividend of UK£0.05 per share at 1.2% yield

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased to UK£5.82

Science Group plc (AIM:SAG) signed a letter of intent to acquire remaining stakes in TP Group plc (AIM:TPG) from Hargreave Hale Limited, Asset Management Arm for approximately £17.53 million.

Price target increased to UK£5.82

First half 2022 earnings released: EPS: UK£0.10 (vs UK£0.11 in 1H 2021)

Science Group plc to Report First Half, 2022 Results on Jul 25, 2022

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,551,046 shares, representing 10% of its issued share capital, under the authorization approved on May 18, 2022.

Science Group plc Intends to Appoint Susan Clement Davies to the Board as a Non-Executive Director

Upcoming dividend of UK£0.05 per share

Less than half of directors are independent

An Intrinsic Calculation For Science Group plc (LON:SAG) Suggests It's 30% Undervalued

Investor sentiment improved over the past week

Science Group plc Appoints Jon Brett as Finance Director, Effective 1 March 2022

Price target increased to UK£5.61

Science Group plc Provides Revenue Guidance for the Full Year Ended December 31, 2021

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,123,839 shares, representing 9.8% of its issued share capital, under the authorization approved on May 19, 2021.

Executive Chairman recently sold UK£9.0m worth of stock

Science Group plc has completed a Follow-on Equity Offering in the amount of £18.557276 million.

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.048 in 1H 2020)

Price target increased to UK£5.11

Science Group plc Provides Revenue Guidance for the Six Months to 30 June 2021

Is It Time To Consider Buying Science Group plc (LON:SAG)?

Science Group plc Approves Final Dividend

Upcoming dividend of UK£0.04 per share

Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet

Statutory Profit Doesn't Reflect How Good Science Group's (LON:SAG) Earnings Are

Has Science Group plc's (LON:SAG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.041 loss in FY 2019)

Revenue beats expectations

Shareholders Of Science Group (LON:SAG) Must Be Happy With Their 172% Total Return

Science Group plc Announces Executive Changes

New 90-day high: UK£2.90

Is Science Group (LON:SAG) Using Too Much Debt?

New 90-day high: UK£2.68

Executive Chairman recently sold UK£4.8m worth of stock

Upcoming Dividend of UK£0.02 Per Share

New 90-day high - UK£2.58

New 90-day high - UK£2.43

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines